Financial Results

Summary Version

Consolidated Annual Reports
2020 2021 2022 2023
Currency PLN PLN PLN PLN
Net Sales Revenue (thousands) 4 559 29 947 16 441 1 128
Operating Profit (Loss) (thousands) 487 8 542 -910 -2 695
Gross Profit (Loss) (thousands) 518 8 413 768 -5 302
Net Profit (Loss) (thousands)* 366 6 031 315 -6 203
Depreciation (thousands) 3 414 281 95 152
EBITDA (thousands) 3 901 8 823 -815 -2 543
Assets (thousands) 11 582 13 447 10 270 5 612
Equity (thousands)* 2 422 7 847 8 051 2 456
Number of Shares (thousands) 5 701,081 5 701,081 5 701,081 5 701,081
Earnings per Share (PLN) 0,064 1,058 0,055 -1,088
Book Value per Share (PLN) 0,425 1,376 1,412 0,431
INNO-GENE S.A. Q2 2024 Periodic Report

Auditor

The Management Board of HyEnergy S.A., based in Warsaw (“Company”), announces that the Supervisory Board of the Company, acting pursuant to Article 382 § 1 of the Commercial Companies Code in conjunction with Article 66(4) of the Accounting Act and § 14(2)(f) of the Company’s Articles of Association, has selected Triio Audyt Ltd., based in Warsaw, as the entity authorized to audit the standalone financial statements of HyEnergy S.A. for 2023 and the consolidated financial statements of the HyEnergy S.A. Group for 2023. Triio Audyt Ltd. is registered on the list of entities authorized to audit financial statements maintained by the National Chamber of Statutory Auditors under registration number 4322.